This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.
Alpha-Lipoic Acid (ALA): Alpha-lipoic acid is an antioxidant that might help improve insulin sensitivity and reduce blood sugar levels. Some studies suggest that ALA supplementation might have modest effects on glycemic control in Type 2 diabetes. However, more research is needed to establish its effectiveness and optimal dosage.
Berberine: Berberine is a compound found in certain plants and has been studied for its potential effects on blood sugar control. Some evidence suggests that berberine might help lower blood sugar levels, although its long-term safety and efficacy require further research.
Chromium: Chromium is a mineral that has been studied for its potential role in improving insulin sensitivity. Some studies suggest that chromium supplementation might have modest effects on glucose metabolism, but its impact on Type 2 diabetes management remains uncertain.
Probiotics: While not directly related to blood sugar regulation, some research suggests that probiotics might influence gut health and inflammation, potentially impacting overall health in individuals with Type 2 diabetes. Specific effects on blood sugar control require further investigation.
Omega-3 Fatty Acids: Omega-3 fatty acids found in fish oil might have potential benefits for cardiovascular health and inflammation, which are relevant to individuals with diabetes. Some studies suggest that omega-3 supplementation might have modest effects on lipid profiles but its direct impact on blood sugar control in Type 2 diabetes is not firmly established.
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some
hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription
All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]